These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33148671)

  • 1. Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers.
    Tsang ES; Grisdale CJ; Pleasance E; Topham JT; Mungall K; Reisle C; Choo C; Carreira M; Bowlby R; Karasinska JM; MacMillan D; Williamson LM; Chuah E; Moore RA; Mungall AJ; Zhao Y; Tessier-Cloutier B; Ng T; Sun S; Lim HJ; Schaeffer DF; Renouf DJ; Yip S; Laskin J; Marra MA; Jones SJM; Loree JM
    Clin Cancer Res; 2021 Jan; 27(2):522-531. PubMed ID: 33148671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved detection of clinically relevant fusion transcripts in cancer by machine learning classification.
    Hafstað V; Häkkinen J; Larsson M; Staaf J; Vallon-Christersson J; Persson H
    BMC Genomics; 2023 Dec; 24(1):783. PubMed ID: 38110872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS.
    van Belzen IAEM; Cai C; van Tuil M; Badloe S; Strengman E; Janse A; Verwiel ETP; van der Leest DFM; Kester L; Molenaar JJ; Meijerink J; Drost J; Peng WC; Kerstens HHD; Tops BBJ; Holstege FCP; Kemmeren P; Hehir-Kwa JY
    BMC Cancer; 2023 Jul; 23(1):618. PubMed ID: 37400763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
    Gaonkar KS; Marini F; Rathi KS; Jain P; Zhu Y; Chimicles NA; Brown MA; Naqvi AS; Zhang B; Storm PB; Maris JM; Raman P; Resnick AC; Strauch K; Taroni JN; Rokita JL
    BMC Bioinformatics; 2020 Dec; 21(1):577. PubMed ID: 33317447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of clinically relevant fusions in pediatric cancer.
    LaHaye S; Fitch JR; Voytovich KJ; Herman AC; Kelly BJ; Lammi GE; Arbesfeld JA; Wijeratne S; Franklin SJ; Schieffer KM; Bir N; McGrath SD; Miller AR; Wetzel A; Miller KE; Bedrosian TA; Leraas K; Varga EA; Lee K; Gupta A; Setty B; Boué DR; Leonard JR; Finlay JL; Abdelbaki MS; Osorio DS; Koo SC; Koboldt DC; Wagner AH; Eisfeld AK; Mrózek K; Magrini V; Cottrell CE; Mardis ER; Wilson RK; White P
    BMC Genomics; 2021 Dec; 22(1):872. PubMed ID: 34863095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Landscape of gene fusions in epithelial cancers: seq and ye shall find.
    Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
    Genome Med; 2015 Dec; 7():129. PubMed ID: 26684754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer.
    Kloosterman WP; Coebergh van den Braak RRJ; Pieterse M; van Roosmalen MJ; Sieuwerts AM; Stangl C; Brunekreef R; Lalmahomed ZS; Ooft S; van Galen A; Smid M; Lefebvre A; Zwartkruis F; Martens JWM; Foekens JA; Biermann K; Koudijs MJ; Ijzermans JNM; Voest EE
    Cancer Res; 2017 Jul; 77(14):3814-3822. PubMed ID: 28512242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-seq Fusion Detection in Clinical Oncology.
    Hedges DJ
    Adv Exp Med Biol; 2022; 1361():163-175. PubMed ID: 35230688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing.
    Cieslik M; Chugh R; Wu YM; Wu M; Brennan C; Lonigro R; Su F; Wang R; Siddiqui J; Mehra R; Cao X; Lucas D; Chinnaiyan AM; Robinson D
    Genome Res; 2015 Sep; 25(9):1372-81. PubMed ID: 26253700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast and sensitive validation of fusion transcripts in whole-genome sequencing data.
    Hafstað V; Häkkinen J; Persson H
    BMC Bioinformatics; 2023 Sep; 24(1):359. PubMed ID: 37741966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays.
    Kirchner M; Glade J; Lehmann U; Merkelbach-Bruse S; Hummel M; Lehmann A; Trautmann M; Kumbrink J; Jung A; Dietmaier W; Endris V; Kazdal D; Ploeger C; Evert M; Horst D; Kreipe H; Kirchner T; Wardelmann E; Büttner R; Weichert W; Dietel M; Schirmacher P; Stenzinger A; Pfarr N
    Genes Chromosomes Cancer; 2020 Aug; 59(8):445-453. PubMed ID: 32319699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SFyNCS detects oncogenic fusions involving non-coding sequences in cancer.
    Zhong X; Luan J; Yu A; Lee-Hassett A; Miao Y; Yang L
    Nucleic Acids Res; 2023 Oct; 51(18):e96. PubMed ID: 37638762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Fusion Discovery with INTEGRATE.
    Zhang J; Maher CA
    Methods Mol Biol; 2020; 2079():41-68. PubMed ID: 31728961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data.
    Shah N; Lankerovich M; Lee H; Yoon JG; Schroeder B; Foltz G
    BMC Genomics; 2013 Nov; 14(1):818. PubMed ID: 24261984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-Seq for the detection of gene fusions in solid tumors: development and validation of the JAX FusionSeq™ 2.0 assay.
    Bergeron D; Chandok H; Nie Q; Prego M; Soucy M; Kelly K; Ananda G; Hesse A; Reddi HV
    J Mol Med (Berl); 2022 Feb; 100(2):323-335. PubMed ID: 35013752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target.
    Yakirevich E; Resnick MB; Mangray S; Wheeler M; Jackson CL; Lombardo KA; Lee J; Kim KM; Gill AJ; Wang K; Gowen K; Sun J; Miller VA; Stephens PJ; Ali SM; Ross JS; Safran H
    Clin Cancer Res; 2016 Aug; 22(15):3831-40. PubMed ID: 26933125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets.
    Arbajian E; Puls F; Antonescu CR; Amary F; Sciot R; Debiec-Rychter M; Sumathi VP; Järås M; Magnusson L; Nilsson J; Hofvander J; Mertens F
    Clin Cancer Res; 2017 Dec; 23(23):7426-7434. PubMed ID: 28939748
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent
    Khuong-Quang DA; Brown LM; Wong M; Mayoh C; Sexton-Oates A; Kumar A; Pinese M; Nagabushan S; Lau L; Ludlow LE; Gifford AJ; Rodriguez M; Desai J; Fox SB; Haber M; Ziegler DS; Hansford JR; Marshall GM; Cowley MJ; Ekert PG
    Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33144287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INTEGRATE: gene fusion discovery using whole genome and transcriptome data.
    Zhang J; White NM; Schmidt HK; Fulton RS; Tomlinson C; Warren WC; Wilson RK; Maher CA
    Genome Res; 2016 Jan; 26(1):108-18. PubMed ID: 26556708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy.
    Hsiao SJ; Zehir A; Sireci AN; Aisner DL
    J Mol Diagn; 2019 Jul; 21(4):553-571. PubMed ID: 31075511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.